Assessment of three e-cigarette nicotine blends,when used by current smokers.

Phase 1

• Conditions: Smoking; Other - Research that is not of generic health relevance and not applicable to specific health categories listed above

• Registration Number: ACTRN12614000522617
• Lead Sponsor: Ploom

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-05-16
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Male
• Target Recruitment: 24

Inclusion Criteria

Smoke at least 5 cigarettes per day.

Exclusion Criteria

Impaired lung function

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
This will give the company important information about nicotine levels of the three eblends compared to traditional cigarettes, which will help further product development.<br>The concentration of nicotine entering the blood will be measured for each product using multiple blood samples over time. [Blood samples will be taken before inhaling and at 10 timepoints from 0 to 30 minutes<br>];The amount of carbon monoxide (CO) in exhaled air will be measured for each product using a validated CO measuring device[CO measurement will be taken 1 minute prior to inhalation and at 30 minutes after inhalation commenced.]

Secondary Outcome Measures

Name	Time	Method
none[none]